Apyx Medical (APYX) Income from Non-Controlling Interests (2013 - 2026)
Apyx Medical's (APYX) quarterly Income from Non-Controlling Interests came in at -$35000.0 in Q1 2026, down 59.09% YoY from -$85555.6 in Q1 2025, and down 159.32% on a QoQ basis from $59000.0 in Q4 2025.
Apyx Medical (APYX) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends
Apyx Medical (APYX) has 10 years of Income from Non-Controlling Interests data on file, last reported at -$35000.0 in Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 59.09% year-over-year to -$35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93000.0 (up 189.42% YoY) and the FY2025 annual result came in at $106000.0, up 210.42% from the prior year.
- Income from Non-Controlling Interests fell to -$35000.0 in Q1 2026, from $59000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $59000.0 in Q4 2025 to a low of -$49000.0 in Q1 2023.
- A 5-year average of -$15058.8 and a median of -$23000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests plunged 475.0% — and 2025, when it surged 290.32%.
- Tracing APYX's Income from Non-Controlling Interests over 5 years: stood at -$16000.0 in 2022, then dropped by 6.25% to -$17000.0 in 2023, then sank by 82.35% to -$31000.0 in 2024, then surged by 290.32% to $59000.0 in 2025, then tumbled by 159.32% to -$35000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$35000.0 (Q1 2026), $59000.0 (Q4 2025), and $29000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 900,000.00 |
| 10 | Apyx Medical | 135.93 Mn | 108.32 Mn | 8.87 Mn | 171,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 171,000.00 |
| Mar 31, 2026 | -35,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | -31,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -17,000.00 |
| Sep 30, 2023 | -46,000.00 |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | -31,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | -12,000.00 |